Debt-to-equity of ImmunoGen, Inc. from 31 Mar 2012 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ImmunoGen, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2023.
  • ImmunoGen, Inc. Debt-to-equity for the quarter ending 30 Sep 2023 was 63%, a 7.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ImmunoGen, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2023 63% -5.3% -7.8% 30 Sep 2023
Q2 2023 81% +0.65% +0.81% 30 Jun 2023
Q1 2023 101% -5.5% -5.1% 31 Mar 2023
Q4 2022 81% -79% -49% 31 Dec 2022
Q3 2022 69% -226% -77% 30 Sep 2022
Q2 2022 80% -418% -84% 30 Jun 2022
Q1 2022 106% -842% -89% 31 Mar 2022
Q4 2021 160% -6230% -97% 31 Dec 2021
Q3 2021 295% +1107% 30 Sep 2021
Q2 2021 498% +1152% 30 Jun 2021
Q1 2021 948% +1507% 31 Mar 2021
Q4 2020 6390% +6916% 31 Dec 2020
Q3 2020 -812% -34% -4.3% 30 Sep 2020
Q2 2020 -654% +2734% +81% 30 Jun 2020
Q1 2020 -559% -1581% -155% 31 Mar 2020
Q4 2019 -527% -1584% -150% 31 Dec 2019
Q3 2019 -779% -2243% -153% 30 Sep 2019
Q2 2019 -3388% -1760% -108% 30 Jun 2019
Q1 2019 1022% +1407% 31 Mar 2019
Q4 2018 1057% +1341% 31 Dec 2018
Q3 2018 1464% +1691% 30 Sep 2018
Q2 2018 -1629% -1403% -621% 30 Jun 2018
Q1 2018 -385% -119% -45% 31 Mar 2018
Q4 2017 -284% +50% +15% 31 Dec 2017
Q3 2017 -227% +248% +52% 30 Sep 2017
Q2 2017 -226% +682% +75% 30 Jun 2017
Q1 2017 -266% +9439% +97% 31 Mar 2017
Q4 2016 -334% -1325% -134% 31 Dec 2016
Q3 2016 -475% -840% -230% 30 Sep 2016
Q2 2016 -908% -1117% -535% 30 Jun 2016
Q1 2016 -9706% -9816% -8924% 31 Mar 2016
Q4 2015 992% +891% +881% 31 Dec 2015
Q3 2015 366% +273% +296% 30 Sep 2015
Q2 2015 209% +130% +166% 30 Jun 2015
Q1 2015 110% +39% +55% 31 Mar 2015
Q4 2014 101% +36% +54% 31 Dec 2014
Q3 2014 92% +23% +34% 30 Sep 2014
Q2 2014 78% +11% +17% 30 Jun 2014
Q1 2014 71% -1.8% -2.5% 31 Mar 2014
Q4 2013 66% -14% -18% 31 Dec 2013
Q3 2013 69% -14% -17% 30 Sep 2013
Q2 2013 67% -18% -21% 30 Jun 2013
Q1 2013 73% +1.8% +2.5% 31 Mar 2013
Q4 2012 80% 31 Dec 2012
Q3 2012 83% 30 Sep 2012
Q2 2012 85% 30 Jun 2012
Q1 2012 71% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.